PRESS RELEASE published on 03/04/2026 at 07:44, 2 months 14 days ago Viromed Medical AG signs letter of intent to acquire relyon plasma GmbH – Strategic step toward integrated platform for cold plasma technology Viromed Medical AG signs letter of intent to acquire relyon plasma GmbH, a key strategic step towards an integrated platform for cold plasma technology. The acquisition aims to strengthen Viromed's technological position and expand its market presence Acquisition Strategic Integration Viromed Medical AG Cold Plasma Technology Relyon Plasma GmbH
BRIEF published on 03/03/2026 at 17:50, 2 months 14 days ago Viromed Medical AG va acquérir Relieon Plasma GmbH Dispositifs Médicaux Fusions Et Acquisitions Viromed Medical AG Technologie Du Plasma Froid Relion Plasma GmbH
BRIEF published on 03/03/2026 at 17:50, 2 months 14 days ago Viromed Medical AG to Acquire relyon plasma GmbH Medical Devices Mergers And Acquisitions Viromed Medical AG Cold Plasma Technology Relyon Plasma GmbH
PRESS RELEASE published on 03/03/2026 at 17:45, 2 months 14 days ago EQS-Adhoc: Viromed Medical AG signs letter of intent to acquire relyon plasma GmbH Viromed Medical AG signs letter of intent to acquire relyon plasma GmbH, expanding its value chain and gaining expertise in atmospheric plasma technology Acquisition Letter Of Intent Plasma Technology Viromed Medical AG Relyon Plasma GmbH
BRIEF published on 02/16/2026 at 10:19, 3 months 2 days ago Viromed Medical AG fait progresser un traitement pulmonaire unique Résistance Aux Antibiotiques Thérapie Par Plasma Froid Soins Intensifs Infections Pulmonaires Validation Préclinique
BRIEF published on 02/16/2026 at 10:19, 3 months 2 days ago Viromed Medical AG Advances with Unique Lung Treatment Antibiotic Resistance Cold Plasma Therapy Intensive Care Lung Infections Preclinical Validation
PRESS RELEASE published on 02/16/2026 at 10:14, 3 months 2 days ago Viromed Medical AG: Globally unique preclinical data base – Saarland validation as key step toward first physical lung application Viromed Medical AG presents globally unique preclinical data on cold plasma therapy for lung infections, with Saarland validation confirming a key step towards clinical application Preclinical Data Viromed Medical AG Cold Plasma Therapy Lung Infections Saarland Validation
BRIEF published on 01/27/2026 at 16:48, 3 months 21 days ago MHH to Unveil Cold Plasma Therapy Research for Lung Applications Medical Innovation Antibiotic Resistance Viromed Medical AG Cold Plasma Therapy Lung Infections
BRIEF published on 01/27/2026 at 16:48, 3 months 21 days ago MHH dévoilera ses recherches sur la thérapie par plasma froid pour les applications pulmonaires. Innovation Médicale Résistance Aux Antibiotiques Viromed Medical AG Thérapie Par Plasma Froid Infections Pulmonaires
PRESS RELEASE published on 01/27/2026 at 16:43, 3 months 21 days ago MHH to Present Scientific Findings on Cold Plasma Therapy for Pulmonary Application at Press Conference in February 2026 MHH to present groundbreaking cold plasma therapy for pulmonary application at press conference in February 2026, addressing urgent clinical need worldwide Scientific Findings Press Conference Viromed Medical AG Cold Plasma Therapy Pulmonary Application
Published on 05/18/2026 at 14:37, 1 hour 31 minutes ago Tyson Fury, The Gypsy King, Joins Datavault AI as International Spokesperson to Champion Athlete Data Monetization
Published on 05/18/2026 at 14:30, 1 hour 38 minutes ago Ebola Global Health Emergency Needs a Broad-Spectrum Drug - NV-387 is a Strong Potential Candidate, Says NanoViricides
Published on 05/16/2026 at 01:15, 2 days 14 hours ago Findev Inc. Announces a New Member of the Board of Directors
Published on 05/18/2026 at 15:50, 18 minutes ago BLUETTI at WUF13: Partnering with UN-Habitat to Power Global Sustainable Urbanization
Published on 05/18/2026 at 15:41, 27 minutes ago Form 8.3 - The Vanguard Group, Inc.: Tate & Lyle plc
Published on 05/18/2026 at 15:40, 27 minutes ago Form 8.3 - The Vanguard Group, Inc.: Spire Healthcare Group plc
Published on 05/18/2026 at 11:06, 5 hours 2 minutes ago GUILLEMOT CORPORATION: Weekly report share buyback From May 11th to May 15th 2026
Published on 05/18/2026 at 11:06, 5 hours 2 minutes ago GUILLEMOT CORPORATION : Déclaration hebdomadaire des transactions sur actions propres du 11 mai 2026 au 15 mai 2026
Published on 05/18/2026 at 08:30, 7 hours 38 minutes ago Thales appoints Jérémie Papin Senior Executive Vice-President, Finance and Information Systems
Published on 05/18/2026 at 08:30, 7 hours 38 minutes ago Thales nomme Jérémie Papin Directeur général, Finance et Systèmes d’Information
Published on 05/15/2026 at 15:08, 3 days 1 hour ago Notice of exercise of early redemption option of the subordinated note ISIN : FR0010203026